ANTINEOPLASTICS TOXICITY
Clinical trials for ANTINEOPLASTICS TOXICITY explained in plain language.
Never miss a new study
Get alerted when new ANTINEOPLASTICS TOXICITY trials appear
Sign up with your email to follow new studies for ANTINEOPLASTICS TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer survivors may finally ditch heart pills: major trial underway
Disease control Recruiting nowThis study looks at whether cancer survivors who had heart problems from their cancer treatment can safely stop taking heart failure medications once their heart function is back to normal. About 335 adults who have finished cancer therapy and are on heart medications will be ran…
Matched conditions: ANTINEOPLASTICS TOXICITY
Phase: PHASE4 • Sponsor: Dinesh Thavendiranathan • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New immunotherapy combo may save bladders in cancer patients
Disease control Recruiting nowThis phase 2 trial tests two immunotherapy drugs, nivolumab and relatlimab, given before surgery for stage II-IIIa bladder cancer. The goal is to see if the combination can eliminate the tumor, allowing patients to keep their bladder instead of having it removed. About 90 partici…
Matched conditions: ANTINEOPLASTICS TOXICITY
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 26, 2026 12:50 UTC